Interview with Stephen Becker, M.D.

by John James:

KP-1461, an experimental HIV drug already in a phase II trial,
works so differently from other antiretrovirals that at first glance
it looked like science fiction, and we found it hard to take
seriously as a current possibility today. In fact this drug is highly
credible, and based on elegant science that goes back at least 25
years. KP-1461 is the only antiretroviral in human use or testing
that can eradicate HIV from laboratory cell cultures. No one knows
how it will work in people -- but we might know by the second quarter
of 2008, when the current phase II trial could be complete. AIDS
Treatment News interviewed Dr. Stephen Becker, a leading AIDS
physician and researcher who is now vice president of clinical
development at Koronis Pharmaceuticals, in Seattle, Washington.
Full article: <http://www.aidsnews.org/2007/09/kp-1461.html